About Medibruk Pharma Private Limited
Data last updated:
Medibruk Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC347649. Its GSTIN is 06AAMCM5434B1ZO (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Deepak Bambha and Verinder Chhabra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹70.5 Lakh, a decline of 86% compared to the previous year. For the same year it recorded a net profit of ₹90,523 (net margin 1.3%) and EBITDA of ₹1.57 Lakh (EBITDA margin 2.2%). Revenue has declined at a compounded annual rate (CAGR) of 54% over three years.
For more details, the company can be reached via its website zeelab.co.in.
Company details
Contact details
Medibruk Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is zeelab.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medibruk Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medibruk Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medibruk Pharma Private Limited, buy the company report.
Financials of Medibruk Pharma Private Limited
FY 2024 filings availableMedibruk Pharma Private Limited reported revenue of ₹70.5 Lakh (down 86% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 54% over three years, including a 86% fall in the latest year. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹90,523 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medibruk Pharma Private Limited, buy the company report.
Board of directors of Medibruk Pharma Private Limited
Medibruk Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Bambha Also directs: Adkin Bioceuticals Private Limited, Zee Laboratories Limited | Director | 27 Mar 2019 | 7 Years 6 Months | Current |
| Verinder Chhabra Also directs: Klokter Life Sciences Private Limited, Klokter Healthcare Private Limited, Zee Biosciences Private Limited and 5 more | Director | 27 Mar 2019 | 7 Years 6 Months | Current |
Peer comparison
Medibruk Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Austin Infratech Private Limited | ₹70.52 Lakh (FY 2022) | -27.0% | Greater Noida, Uttar Pradesh, India | |||
| Saffron Vinimay Private Limited | ₹70.51 Lakh (FY 2024) | 572.0% | Kolkata, West Bengal, India | |||
| Hoffman Trade Enterprise Private Limited | ₹70.51 Lakh (FY 2021) | 156.0% | Navrangpura, Gujarat, India | |||
| Shangi Foods Private Limited | ₹70.51 Lakh (FY 2018) | 95.0% | Mumbai, Maharashtra, India | |||
| Shreeananta Grains and Commodities Private Limited | ₹70.51 Lakh (FY 2024) | 140.0% | Mumbai, Maharashtra, India | |||
| Medibruk Pharma Private Limitedthis company | ₹70.5 Lakh (FY 2024) | ₹90,523 | 1.3% | -86.0% | New Delhi, Delhi, India | |
| Vimal Cottex Private Limited | ₹70.5 Lakh (FY 2024) | 19.0% | Kolkata, West Bengal, India | |||
| Parveen Trading Pvt Ltd | ₹70.49 Lakh (FY 2025) | 5.0% | Guwahati, Assam, India | |||
| Suparna Herbs (India) Private Limited | ₹70.48 Lakh (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Ganganagar Commercial Private Limited | ₹70.47 Lakh (FY 2025) | -81.0% | Sri Ganganagar, Rajasthan, India | |||
| Wavelink Commercials Private Limited | ₹70.47 Lakh (FY 2019) | -91.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Medibruk Pharma Private Limited, buy the company report.
Auditor
Medibruk Pharma Private Limited is audited by ANURAG KHANNA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANURAG KHANNA | FY 2023 | 512943 |
Shareholding
The shareholding of Medibruk Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Medibruk Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medibruk Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medibruk Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medibruk Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAMCM5434B1ZO | Haryana | Active | 24 Apr 2019 |
To see the full GST registrations and return filing status of Medibruk Pharma Private Limited, buy the company report.
Recent activity
Medibruk Pharma Private Limited has 7 board changes on record since 2019: 2 appointments and 5 cessations. The latest: Deepak Bambha ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Medibruk Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 March 2019 (7+ years old) and is registered under CIN U51909DL2019PTC347649.
Medibruk Pharma has 2 current directors:
- Deepak Bambha - Director
- Verinder Chhabra - Director
The latest financial statements of Medibruk Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Medibruk Pharma is 06AAMCM5434B1ZO, registered in Haryana.
The CIN (Corporate Identification Number) of Medibruk Pharma is U51909DL2019PTC347649. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medibruk Pharma was incorporated on 25 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medibruk Pharma by revenue are Austin Infratech Private Limited, Saffron Vinimay Private Limited, Hoffman Trade Enterprise Private Limited, Shangi Foods Private Limited, Shreeananta Grains and Commodities Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Deepak Bambha ceased to be Additional Director on 31 Dec 2020. Verinder Chhabra ceased to be Additional Director on 31 Dec 2020. Dinesh Kakar ceased to be Director on 21 Dec 2020. Medibruk Pharma has 7 board changes on record in total.
Medibruk Pharma can be reached through the website zeelab.co.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Medibruk Pharma is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
Medibruk Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.